Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris

Takes responsibility for all global research and development activities at the Canadian firm

Richard Sachse

Canadian biopharmaceutical firm Aeterna Zentaris has hired Richard Sachse as Senior Vice President, Chief Scientific Officer (CSO). He was previously Vice President, Head of Global Translational Medicine at Boehringer Ingelheim.

As CSO, he will be responsible for all global research and development activities, while also serving on the corporate Operating Committee.

Sachse has held increasingly responsible positions with several leading pharmaceutical companies, including Bayer, Schwarz Pharma, UCB and Boehringer Ingelheim, overseeing major drug development programmes in a variety of therapeutic areas, including oncology and endocrinology.